15,28 Ray-Coquard et al. reported the use of RG7112 in 20 liposarcoma patients, and while many sustained gastrointestinal toxicity, the drug was found to activate the p53 pathway and demonstrate encouraging results.17 The gene discussed is TP53; the disease is liposarcoma.